HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic ocular zoster.

Abstract
In a prospective open trial 40 patients suffering from acute herpes zoster ophthalmicus were treated with systemic acyclovir. An additional 10 patients were treated by topical acyclovir alone and dexamethasone eye-drops were administered to 5 of them to suppress ocular inflammation. In the topical treatment group the period of new skin lesion formation and progression of ocular inflammatory signs were significantly prolonged. Therapy with systemic acyclovir however resulted in a quick and complete resolution of ocular inflammation in all patients. Chronic ocular inflammation developed in 4 out of 10 patients treated with topical acyclovir. We consider chronic ocular zoster as a distinct clinical entity, possibly expressing a failing local immune response against VZV.
AuthorsM J Zaal, P C Maudgal, E Rietveld, E P Suir
JournalCurrent eye research (Curr Eye Res) Vol. 10 Suppl Pg. 125-30 ( 1991) ISSN: 0271-3683 [Print] England
PMID1864089 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antiviral Agents
  • brivudine
  • Dexamethasone
  • Bromodeoxyuridine
  • Acyclovir
Topics
  • Acyclovir (therapeutic use)
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antiviral Agents (therapeutic use)
  • Bromodeoxyuridine (analogs & derivatives, therapeutic use)
  • Chronic Disease
  • Conjunctivitis (drug therapy, etiology)
  • Dexamethasone (therapeutic use)
  • Drug Administration Routes
  • Female
  • Herpes Zoster Ophthalmicus (drug therapy)
  • Humans
  • Keratitis, Dendritic (drug therapy, etiology)
  • Male
  • Middle Aged
  • Prospective Studies
  • Scleritis (drug therapy, etiology)
  • Skin Diseases (drug therapy, etiology)
  • Uveitis, Anterior (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: